We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Relationship of Serum Cortisol and Serum Sodium Analyzed

By LabMedica International staff writers
Posted on 19 Jul 2017
Print article
Image: The Advia Centaur XP immunoassay analyzer (Photo courtesy of Siemens Healthcare).
Image: The Advia Centaur XP immunoassay analyzer (Photo courtesy of Siemens Healthcare).
Hyponatremia is the most common electrolyte disorder encountered by the clinical biochemist, and is associated with a significant mortality and hypernatremia is also a risk factor for mortality in critically ill patients.

Adrenal insufficiency is an uncommon cause of hyponatremia, but one that should not be overlooked because an Addisonian crisis, once recognized, can be easily and safely treated with fluid replacement and corticosteroid. Clinical practice guidelines on hyponatremia advise that primary or secondary adrenal insufficiency should always be considered as a potential cause of hyponatremia.

Medical laboratory scientists at the Leeds General Infirmary (Leeds, UK) defined severe hyponatremia as a sodium concentration equal to or less than 120 mmol/L and severe hypernatraemia was defined as a sodium concentration equal to or greater than 150 mmol/L. The reference range for serum cortisol in a morning sample at the Leeds Teaching Hospitals NHS Trust is 150 to 600 nmol/L. Data was gathered on samples where both serum sodium and cortisol that had been requested from the laboratory information management system for 23 months (January 1, 2013, until November 30, 2014).

Serum sodium and cortisol were measured on Advia 1800 or 2400 and Centaur XP analyzers respectively. Analysis of the data from 3,268 patients revealed a trend showing higher cortisol concentrations in patients who were severely hypo- or hypernatremic. The median cortisol concentration for patients with sodium equal to or less than 110 mmol/L was 856 nmol/L, and there was a gradual decrease in cortisol over the sodium range equal to or less than 110 to 150 mmol/L. Patients with sodium equal to or greater than 151 mmol/L had a median cortisol of 725 nmol/L, and 42% of the 978 patients with serum sodium of less than or equal to 120 mmol/L had serum cortisol measured within two weeks, of whom 1.7% were diagnosed with adrenal insufficiency.

The authors concluded that despite the relative rarity of endocrine causes of hyponatremia, adrenal insufficiency should remain an important consideration in the clinical workup of the hypernatremic patient due to the severe consequences of failure to treat with glucocorticoid replacement and volume repletion. The dataset shows rising cortisol in response to hypo- or hypernatremia, in keeping with the stress response to illness. The data show that adrenal insufficiency is a rare cause of hyponatremia, which may be overlooked. The full study will be published in the August 2017 issue of the journal Practical Laboratory Medicine.

Related Links:
Leeds General Infirmary

Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Myeloperoxidase Assay
IDK MPO ELISA
New
Respiratory Bacterial Panel
Real Respiratory Bacterial Panel 2

Print article

Channels

Molecular Diagnostics

view channel
Image: The Mirvie RNA platform predicts pregnancy complications months before they occur using a simple blood test (Photo courtesy of Mirvie)

RNA-Based Blood Test Detects Preeclampsia Risk Months Before Symptoms

Preeclampsia remains a major cause of maternal morbidity and mortality, as well as preterm births. Despite current guidelines that aim to identify pregnant women at increased risk of preeclampsia using... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Deliver Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.